Vredenburgh, J. J., Desjardins, A., Reardon, D. A., Peters, K. B., Kirkpatrick, J. P., Herndon, J. E., … Friedman, H. S. (2011). THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME. NEURO-ONCOLOGY, 13, 89–90.

Vredenburgh, James J., Annick Desjardins, David A. Reardon, Katherine B. Peters, John P. Kirkpatrick, James E. Herndon, April D. Coan, et al. “THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME.” NEURO-ONCOLOGY 13 (November 1, 2011): 89–90.

Vredenburgh JJ, Desjardins A, Reardon DA, Peters KB, Kirkpatrick JP, Herndon JE, et al. THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME. NEURO-ONCOLOGY. 2011 Nov 1;13:89–90.

Vredenburgh, James J., et al. “THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME.” NEURO-ONCOLOGY, vol. 13, OXFORD UNIV PRESS INC, Nov. 2011, pp. 89–90.

Vredenburgh JJ, Desjardins A, Reardon DA, Peters KB, Kirkpatrick JP, Herndon JE, Coan AD, Bailey L, Janney D, Lu C, Friedman HS. THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2011 Nov 1;13:89–90.